Persistent CD4+T cell depression following combination alefacept and methotrexate therapy

International Journal of Dermatology

Volumn 47, Issue 11, 2008, Pages 1204-1206

  Bansal, Cheryl ^a   Leonardi, Craig L ^b   Van Voorhees, Abby S ^c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; METHOTREXATE;

ADOLESCENT; AGED; ANAMNESIS; ANEMIA; CASE REPORT; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; DISEASE PREDISPOSITION; DRUG DOSE REDUCTION; DRUG POTENTIATION; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EFFECTOR CELL; FEMALE; HUMAN; LETTER; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; MEMORY CELL; MONOTHERAPY; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; SIDE EFFECT; ULTRAVIOLET B RADIATION;

ADOLESCENT; AGED; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; DERMATOLOGIC AGENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; PSORIASIS; RECOMBINANT FUSION PROTEINS;

EID: 55449094188     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03642.x     Document Type: Letter

References (5)

1. Lebwohl M, Christophers E, Langley R, et al. An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Arch Dermatol 2003; 139: 719-727.
2. Gade JN. Clinical update on alefacept: Consideration for use in patients with psoriasis. J Manag Care Pharm 2004; 10: S33-S37.
3. Mease PJ, Gladmann DD, Keystone EC. Alefacept in combination with methotrexate for the treatment of psoriatic arthritis: Results of a randomized, double-blind, placebo-controlled study. Arthritis Rheum 2006; 54: 1638-1645.
4. Krueger GG. Selective targeting of T cell subsets: Focus on alefacept - a remittive therapy for psoriasis. Exp Opin Biol Ther 2002; 2: 431-441.
5. Frampton J, Wagstaff A. Alefacept. Am J Clin Dermatol 2003; 4: 277-286.